Copanlisib-[d4]
Copanlisib-[d4], is the labelled analogue of Copanlisib. Copanlisib is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib is a drug which is approved by US FDA for the treatment of adult patients experiencing relapsed follicular lymphoma.
| Supplier | BOC Sciences |
|---|---|
| Product # | BLP-002332 |
| Pricing | Inquire |
| Cas | 2168537-44-6 |
| Molecular Weight | 484.54 |
| Molecular Formula | C23H24D4N8O4 |